The product is expected to be shipped in the first quarter of 2009, subject to regulatory marketing approvals and product reimbursement arrangements. A Catrix Wound Dressing utilises bovine cartilage that has been refined into a fine, white powder. It has been shown in extensive clinical testing to be an effective aid in the healing of wounds that are resistant to the healing process. The product has been approved by the United States FDA for the management of first and second degree burns as well as decubitus ulcers, venous stasis and diabetic ulcers and post-radiation dermatitis.
Comments on this story may be sent to admin@m2.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index